Invezz

Daxor (DXR)

NasdaqMarket Closed

Daxor Corporation is a medical technology and biotechnology company focused on blood volume analysis, a diagnostic area used to assess whether a patient has too much, too little, or an imbalanced distribution of blood volume. The company’s principal product is the BVA-100 Blood Volume Analyzer, a laboratory-based system designed to provide quantified measurements of total blood volume, plasma volume, and red blood cell volume.

The company positions its technology for use in conditions where fluid status is clinically important, including heart failure, critical care, hypertension, kidney disease, blood loss, and other settings in which standard vital signs or indirect tests may not provide a complete picture. The BVA-100 uses a tracer-based diagnostic method and is intended to give physicians objective data that can support decisions about diuretics, transfusions, intravenous fluids, and other therapies.

Daxor’s business model centers on expanding adoption of its blood volume testing platform among hospitals, academic medical centers, and specialist practices. As a small-cap healthcare company, its prospects are closely tied to clinical validation, reimbursement, physician education, and the broader push toward more data-driven patient management. Its technology addresses a specific niche rather than a broad consumer market, which makes execution, regulatory compliance, and evidence generation especially important.

For investors, Daxor represents exposure to a specialized diagnostics company attempting to commercialize a differentiated test in cardiovascular and acute-care medicine. Its distinctive feature is the focus on direct blood volume measurement, an area that remains less widely used than many conventional diagnostic tools despite its potential relevance in complex fluid-management decisions.

10.90USD
+0.82(+8.14%)

Last updated

Market Cap
$58,845,211
P/E
P/FCF
P/S
Enterprise Value
Sector
Industrials
Industry
Surgical and Medical Instruments and Apparatus
Address
350 FIFTH AVENUE, NEW YORK, NY, 10118
Market Cap
$58,845,211
Enterprise Value
P/E
P/B
P/S
EV / EBITDA
EV / Sales
EPS
Dividend Yield
P/FCF
P/CF
Free Cash Flow
ROE
ROA
Debt / Equity
Current Ratio
Quick Ratio
Cash
Avg Volume
Fundamentals Snapshot Price

Financial statements are not available for this listing.

KindFilingDateLink
edgar indexN-PX — DAXOR CORPView Filing
edgar indexN-CSR — DAXOR CORPView Filing
edgar indexNPORT-P — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index8-K — DAXOR CORPView Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — DesRosiers CalebView Filing
form 4Form 4 — Feuer EdwardView Filing
form 4Form 4 — Cremisi Henry D.View Filing
form 4Form 4 — Goudie Joy S.View Filing
form 4Form 4 — Feldschuh Jonathan AdamView Filing
form 4Form 4 — Feldschuh Michael RichardView Filing
form 4Form 4 — Michel Robert JView Filing
edgar index40-8F-2/A — DAXOR CORPView Filing
edgar indexDEF 14A — DAXOR CORPView Filing
edgar indexNT NPORT-P — DAXOR CORPView Filing
edgar index40-8F-2/A — DAXOR CORPView Filing
edgar index40-17F2 — DAXOR CORPView Filing
edgar index40-17F2 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
form 4Form 4 — Feldschuh Michael RichardView Filing
edgar indexN-CEN/A — DAXOR CORPView Filing
edgar index40-17F2 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
form 4Form 4 — Michel Robert JView Filing
edgar index4 — DAXOR CORPView Filing
form 4Form 4 — Jefferies JohnView Filing
form 4Form 4 — Jefferies JohnView Filing
edgar indexN-CEN — DAXOR CORPView Filing
edgar indexNPORT-P — DAXOR CORPView Filing
edgar indexN-CSR — DAXOR CORPView Filing
edgar index40-8F-2 — DAXOR CORPView Filing
edgar index424B4 — DAXOR CORPView Filing
edgar index8-K — DAXOR CORPView Filing
eight k text8-K — 8-KView Filing
edgar index8-K — DAXOR CORPView Filing
edgar index424B3 — DAXOR CORPView Filing
eight k text8-K — 8-KView Filing
edgar index424B3 — DAXOR CORPView Filing
edgar indexEFFECT — DAXOR CORPView Filing
edgar indexN-CSR/A — DAXOR CORPView Filing
edgar indexN-CEN/A — DAXOR CORPView Filing
edgar indexN-2/A — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
edgar index4 — DAXOR CORPView Filing
form 4Form 4 — Feldschuh Jonathan AdamView Filing
form 4Form 4 — Michel Robert JView Filing
edgar index4 — DAXOR CORPView Filing
edgar indexNPORT-P — DAXOR CORPView Filing
form 4Form 4 — Jefferies JohnView Filing
edgar indexN-2/A — DAXOR CORPView Filing
edgar indexN-CSR/A — DAXOR CORPView Filing
edgar index3 — DAXOR CORPView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing
form 3Form 3 — Jefferies JohnView Filing